116 related articles for article (PubMed ID: 24583378)
1. Novel mixed ligand di-n-butyltin(IV) complexes derived from acylpyrazolones and fluorinated benzoic acids: synthesis, characterization, cytotoxicity and the induction of apoptosis in Hela cancer cells.
Zhao B; Shang X; Xu L; Zhang W; Xiang G
Eur J Med Chem; 2014 Apr; 76():87-97. PubMed ID: 24583378
[TBL] [Abstract][Full Text] [Related]
2. Novel di-n-butyltin(IV) derivatives: Synthesis, high levels of cytotoxicity in tumor cells and the induction of apoptosis in KB cancer cells.
Shang X; Ding N; Xiang G
Eur J Med Chem; 2012 Feb; 48():305-12. PubMed ID: 22226547
[TBL] [Abstract][Full Text] [Related]
3. Triphenyltin(IV) benzoates with diazenyl/imino scaffold exhibiting remarkable apoptosis mediated by reactive oxygen species.
Basu Baul TS; Dutta D; Duthie A; Prasad R; Rana NK; Koch B; Tiekink ERT
J Inorg Biochem; 2017 Aug; 173():79-92. PubMed ID: 28505480
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, crystal structures, cytotoxicity and qualitative structure-activity relationship (QSAR) of cis-bis{5-[(E)-2-(aryl)-1-diazenyl]quinolinolato}di-n-butyltin(IV) complexes, (n)Bu2Sn(L)2.
Basu Baul TS; Mizar A; Chandra AK; Song X; Eng G; Jirásko R; Holcapek M; de Vos D; Linden A
J Inorg Biochem; 2008 Sep; 102(9):1719-30. PubMed ID: 18571240
[TBL] [Abstract][Full Text] [Related]
5. Organotin(IV) complexes derived from Schiff base N'-[(1E)-(2-hydroxy-3-methoxyphenyl)methylidene]pyridine-4-carbohydrazone: synthesis, in vitro cytotoxicities and DNA/BSA interaction.
Hong M; Geng H; Niu M; Wang F; Li D; Liu J; Yin H
Eur J Med Chem; 2014 Oct; 86():550-61. PubMed ID: 25216377
[TBL] [Abstract][Full Text] [Related]
6. Polynuclear diorganotin(IV) complexes with arylhydroxamates: Syntheses, structures and in vitro cytotoxic activities.
Shang X; Cui J; Wu J; Pombeiro AJ; Li Q
J Inorg Biochem; 2008 Apr; 102(4):901-9. PubMed ID: 18234346
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of a new mixed-ligand complex di-n-butyl-(4-chlorobenzohydroxamato)tin(IV) chloride.
Li Y; Li Y; Niu X; Jie L; Shang X; Guo J; Li Q
J Inorg Biochem; 2008 Sep; 102(9):1731-5. PubMed ID: 18573534
[TBL] [Abstract][Full Text] [Related]
8. Diorganotin(IV) derivatives of substituted benzohydroxamic acids with high antitumor activity.
Li Q; da Silva MF; Pombeiro AJ
Chemistry; 2004 Mar; 10(6):1456-62. PubMed ID: 15034889
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of novel dibutyltin carboxylates of aminoglucosyl derivatives.
Li W; Zhang ZW; Ren SM; Sibiril Y; Parent Massin D; Jiang T
Chem Biol Drug Des; 2009 Jun; 73(6):682-6. PubMed ID: 19635061
[TBL] [Abstract][Full Text] [Related]
10. Syntheses, molecular structures, electrochemical behavior, theoretical study, and antitumor activities of organotin(IV) complexes containing 1-(4-chlorophenyl)-1-cyclopentanecarboxylato ligands.
Shang X; Meng X; Alegria EC; Li Q; Guedes da Silva MF; Kuznetsov ML; Pombeiro AJ
Inorg Chem; 2011 Sep; 50(17):8158-67. PubMed ID: 21793560
[TBL] [Abstract][Full Text] [Related]
11. An in vitro comparative assessment with a series of new triphenyltin(IV) 2-/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with anticancer activities: structural modifications, analysis of efficacy and cytotoxicity involving human tumor cell lines.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Duthie A; de Vos D; Verma RP; Englert U
J Inorg Biochem; 2012 Feb; 107(1):119-28. PubMed ID: 22182574
[TBL] [Abstract][Full Text] [Related]
12. New cytotoxic butyltin complexes with 2-sulfobenzoic acid: Molecular interaction with lipid bilayers and DNA as well as in vitro anticancer activity.
Pruchnik H; Kral T; Poradowski D; Pawlak A; Drynda A; Obmińska-Mrukowicz B; Hof M
Chem Biol Interact; 2016 Jan; 243():107-18. PubMed ID: 26585592
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, structural characterization and in vitro cytotoxicity of diorganotin (IV) diimido complexes.
Yin H; Yue C; Hong M; Cui J; Wu Q; Zhang X
Eur J Med Chem; 2012 Dec; 58():533-42. PubMed ID: 23164659
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of the interaction of novel tributyltin(IV) 2/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with an improved cytotoxic profile: synthesis, structure, biological efficacy and QSAR studies.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Pellerito C; Singh P; Verma P; Duthie A; de Vos D; Verma RP; Englert U
J Inorg Biochem; 2010 Sep; 104(9):950-66. PubMed ID: 20553814
[TBL] [Abstract][Full Text] [Related]
15. Butyltin(IV) 2-sulfobenzoates: synthesis, structural characterization and their cytostatic and antibacterial activities.
Pruchnik H; Lis T; Latocha M; Zielińska A; Ułaszewski S; Pelińska I; Pruchnik FP
J Inorg Biochem; 2012 Jun; 111():25-32. PubMed ID: 22484249
[TBL] [Abstract][Full Text] [Related]
16. One-step preparation, structural assignment, and X-ray study of 2,2-di-n-butyl- and 2,2-diphenyl-6-aza-1,3-dioxa-2-stannabenzocyclononen-4-ones derived from amino acids.
Beltrán HI; Zamudio-Rivera LS; Mancilla T; Santillan R; Farfán N
Chemistry; 2003 May; 9(10):2291-306. PubMed ID: 12772304
[TBL] [Abstract][Full Text] [Related]
17. Diversity of complexes based on p-nitrobenzoylhydrazide, benzoylformic acid and diorganotin halides or oxides self-assemble: Cytotoxicity, the induction of apoptosis in cancer cells and DNA-binding properties.
Jiang W; Fan S; Zhou Q; Zhang F; Kuang D; Tan Y
Bioorg Chem; 2020 Jan; 94():103402. PubMed ID: 31718891
[TBL] [Abstract][Full Text] [Related]
18. Butyltin(IV) benzoates: inhibition of thioredoxin reductase, tumor cell growth inhibition, and interactions with proteins.
Navakoski de Oliveira K; Andermark V; von Grafenstein S; Onambele LA; Dahl G; Rubbiani R; Wolber G; Gabbiani C; Messori L; Prokop A; Ott I
ChemMedChem; 2013 Feb; 8(2):256-64. PubMed ID: 23281101
[TBL] [Abstract][Full Text] [Related]
19. New dibutyltin(IV) ladders: Syntheses, structures and, optimization and evaluation of cytotoxic potential employing A375 (melanoma) and HCT116 (colon carcinoma) cell lines in vitro.
Basu Baul TS; Dutta D; Duthie A; Guchhait N; Rocha BGM; Guedes da Silva MFC; Mokhamatam RB; Raviprakash N; Manna SK
J Inorg Biochem; 2017 Jan; 166():34-48. PubMed ID: 27815980
[TBL] [Abstract][Full Text] [Related]
20. Organotin complexes containing carboxylate ligands with maleimide and naphthalimide derived partial structures: TrxR inhibition, cytotoxicity and activity in resistant cancer cells.
Navakoski de Oliveira K; Andermark V; Onambele LA; Dahl G; Prokop A; Ott I
Eur J Med Chem; 2014 Nov; 87():794-800. PubMed ID: 25440880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
